Connect with us

Hi, what are you looking for?

Jewish Business News

World News

Ben-Moshe, Elsztain, Fighting over $78 Million in IDB Stock

Ben-Moshe and Elsztain bought control of IDB last year, from the previous controlling shareholder Nochi Dankner, who got into a debilitating amount of debt.

Ben-Moshe,   Elsztain

Welcome to the next round in the feud between Moti Ben-Moshe and Eduardo-Elsztain, the controlling shareholders in IDB Development Corp. (TASE: IDBD).

The IDB Group is one of Israel’s biggest business groups, holding leading corporations in key business sectors at home and abroad.

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.

Ben-Moshe and Elsztain bought control of IDB last year, from the previous controlling shareholder Nochi Dankner, who got into a debilitating amount of debt.

So Elsztain and Ben-Moshe each put $180 million into IDB, as part of the Dankner settlement, and also promised to invest another $100 million this year.

Now Ben-Moshe has told the Tel Aviv Stock Exchange (TASE) that he demands the right to buy half the securities Elsztain bought, at the price the latter had bought it for. He also demands the right to buy the shares Elsztain transferred to two other companies under his control.

Extra said, “The rights issue and the procedures supporting it were a violation of the shareholders agreement and unacceptable conduct and in bad faith. This follows the violation of the shareholders agreement by [Elsztain’s company] Dolphin even before the rights issue.”

Elsztain, who holds more than half the shares in IDB after the rights issue, will likely enjoy a majority on the company board—with five directors—while Ben-Moshe gets stuck with one director.

Newsletter



Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

Life-Style Health

Medint’s medical researchers provide data-driven insights to help patients make decisions; It is affordable- hundreds rather than thousands of dollars

Entertainment

The Movie The Professional is what made Natalie Portman a Lolita.

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...